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Abstract. 
 
Basement membranes contain several pro-
teoglycans, and those bearing heparan sulfate gly-
cosaminoglycans such as perlecan and agrin usually 
predominate. Most mammalian basement membranes 
also contain chondroitin sulfate, and a core protein, 
bamacan, has been partially characterized. We have 
now obtained cDNA clones encoding the entire bam-
acan core protein of 
 
M
 
r
 
 
 
5
 
 138 kD, which reveal a five 
domain, head-rod-tail configuration. The head and tail 
are potentially globular, while the central large rod 
probably forms coiled-coil structures, with one large 
central and several very short interruptions. This mo-
lecular architecture is novel for an extracellular matrix 
molecule, but it resembles that of a group of intracellu-
lar proteins, including some proposed to stabilize the 
mitotic chromosome scaffold. We have previously pro-
posed a similar stabilizing role for bamacan in the base-
ment membrane matrix. The protein sequence has low 
overall homology, apart from very small NH
 
2
 
- and 
COOH-terminal motifs.
At the junctions between the distal globular domains 
and the coiled-coil regions lie glycosylation sites, with 
up to three N-linked oligosaccharides and probably 
three chondroitin chains. Three other Ser-Gly dipep-
tides are unfavorable for substitution. Fusion protein 
antibodies stained basement membranes in a pattern 
commensurate with bamacan, and they also Western 
blotted bamacan core protein from rat L2 cell cultures. 
The antibodies could also specifically immunoprecipi-
tate an in vitro transcription/translation product from a 
full-length bamacan cDNA. The unusual structure of 
this proteoglycan is indicative of specific functional 
roles in basement membrane physiology, commensu-
rate with its distinct expression in development and 
changes in disease models.
 
B
 
asement
 
 membranes are thin sheetlike structures
that form a highly specialized part of the extracel-
lular matrix, located in immediate proximity to the
surface of epithelial, endothelial, muscle, and peripheral
nerves. They are important in cell migration, differentia-
tion, and growth, during in vivo development, remodeling,
and regeneration. In addition, they may have specialized
functions, e.g., renal glomerular basement membrane and
neuromuscular junction (for reviews see 35, 49, 53). Base-
ment membranes contain proteins from several distinct
families, some of which are characteristic for these struc-
tures, such as type IV collagens, laminins, heparan sulfate
proteoglycans (HSPGs)
 
1
 
, and entactin/nidogen (7, 35, 37,
49, 53). The only proteoglycan core proteins from base-
ment membranes that have been sequenced to date are
perlecan and agrin (7, 37, 51), and the major glycosami-
noglycan type in both cases is heparan sulfate. However, we
have also provided evidence for the presence of chon-
droitin sulfate glycosaminoglycan in basement membranes.
Chondroitin 6-sulfate glycosaminoglycan was demonstrated
first with an mAb in immunohistochemical studies (8), and
later a chondroitin sulfate proteoglycan (CSPG) with a
core protein of 140–150 kD was purified from rat Re-
ichert’s membranes (21). Subsequently, mAbs against the
core protein of a basement membrane CSPG (BM-CSPG)
revealed that nearly all basement membranes in the adult
rat contain BM-CSPG (31, 32, 33). However, in adult rat
kidney, BM-CSPG was distinctly localized to mesangium
and Bowman’s capsule basement membrane, but absent
from the glomerular basement membrane (33). Immuno-
logical evidence also indicated that BM-CSPG was unre-
lated to perlecan and appeared to be a distinct basement
membrane component (11). Developmental studies also
revealed differences in distribution, and perhaps expres-
sion, between perlecan and BM-CSPG (7, 9, 33, 35, 45). In
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: CSPG, chondroitin sulfate proteogly-
can; BM-CSPG, basement membrane CSPG; F, fragment; HSPG, hepa-
ran sulfate proteoglycan; SMC, stabilization of mitotic chromosomes.
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several organ systems, BM-CSPG is expressed late in or-
ganogenesis, suggesting a role in basement membrane sta-
bility. Consistent with this hypothesis, changes in its distri-
bution are also seen in models of disease where basement
membrane stability is compromised (7, 13, 34). This is in
contrast with other components, consistent with distinct
biological function and regulation of this proteoglycan.
In this report the complete cDNA-derived primary struc-
ture of the BM-CSPG core protein is described. This mul-
tidomain core protein, which has an estimated molecular
mass of 138 kD, contains two domains predicted to form
coiled-coil structures, not seen in other proteoglycans.
Moreover, it is unlike any other extracellular matrix mole-
cule so far described. It does, however, have structural fea-
tures in common with proteins described in diverse phyla
with examples from yeast, nematodes, and vertebrates. In
some cases these proteins have roles in stabilizing the
chromosomal scaffold at mitosis (SMC proteins; 18). We
have adopted the name of bamacan (basement mem-
brane-associated chondroitin proteoglycan) based on the
localization and glycosaminoglycan modification of this
molecule (11).
 
Materials and Methods
 
All reagents were of molecular biology grade and obtained from Sigma
Chemical Co. (St. Louis, MO) unless otherwise specified. Radionucleo-
tides [
 
32
 
P]dCTP (3,000 Ci/mmol) and [
 
35
 
S]dATP (1,000 Ci/mmol) were ob-
tained from Amersham Corp. (Arlington Heights, IL). Sepharose and
DEAE-Sephacel were from Pharmacia Fine Chemicals (Piscataway, NJ).
 
Antibodies and cDNA Probes
 
Monoclonal antibody 2D6 against rat BM-CSPG (32) and polyclonal anti-
body R63 raised against mouse chondroitin/dermatan sulfate proteogly-
cans from the Engelbreth-Holm-Swarm tumor matrix have been charac-
terized previously (11). Polyclonal antibodies R664 and R665 were raised
against core protein fusion proteins FP4a and FP15a generated from frag-
ments (F) of the 5
 
9
 
 regions of cDNA clones 4a and 15a of the core protein
in pGEX (Pharmacia Biotech; see Fig. 1). The cDNA probe F15a, corre-
sponding to the 5
 
9
 
 region of clone 15a, was also used in cDNA library
screening and Northern analysis.
 
Library Screening and Identification of Clones
 
A rat yolk sac carcinoma (L2) cDNA library, random and oligo(dT)
primed in Uni-ZAP
 
TM
 
 XR Vector (Stratagene, La Jolla, CA), was
screened with antibody R63 and by hybridization with appropriate cDNA
fragments. Library immunoscreening was according to the Pico Blue pro-
tocol. Briefly, 1 
 
3
 
 10
 
6
 
 plaques were grown in 150-mm plates in LB agar
medium at 42
 
8
 
C for 3.5 h before incubation of the plates at 37
 
8
 
C for 3.5 h
with nitrocellulose filters (Schleicher & Schuell, Keene, NH) pretreated
with 1 mM isopropylthio-
 
b
 
-
 
d
 
-galactoside. Filters were probed with pri-
mary antibody R63, which had been preadsorbed with 
 
Escherichia coli
 
bacterial lysate and Uni-ZAP
 
TM
 
 XR phages, according to published pro-
tocols (2), followed by alkaline phosphatase–conjugated goat anti–rabbit
IgG (affinity purified 1:3,000 dilution) and color development according
to the manufacturer’s instructions (Bio Rad Laboratories, Richmond,
CA). Bluescript SK
 
2
 
 plasmids were obtained from rescreened and puri-
fied positive plaques by in vivo excision according to the Stratagene pro-
tocol.
To extend sequences obtained from immunoscreening in the 5
 
9
 
 direc-
tion, fragment F15a (see Fig. 1) from one of the primary clones (15a) was
used as a cDNA probe to rescreen the cDNA library. One million plaques
were grown and transferred to nitrocellulose filters. These were treated
with 50% formamide, 5
 
3
 
 Denhardt’s solution, 5
 
3
 
 SSC, 0.1% SDS, and
100 
 
m
 
g/ml denatured salmon sperm DNA and hybridized (overnight,
42
 
8
 
C) under the same conditions with 1 
 
3
 
 10
 
6
 
 cpm/ml F15a probe prela-
beled with 
 
32
 
P by random primer extension (Promega, Madison, WI). Fil-
ters were washed twice in 2
 
3
 
 SSC, 0.1% SDS at room temperature for 20
min each, and then twice in 0.2
 
3
 
 SSC, 0.1% SDS at 50
 
8
 
C for 20 min before
air drying and exposure to x-ray film (X-Omat AR; Eastman Kodak Co.,
Rochester, NY).
 
DNA Sequencing and Computer Analysis
 
Plasmids were sequenced by a modified dideoxynucleotide chain termina-
tion method with Sequenase 2.0 (United States Biochemical Corp., Cleve-
land, OH) using either polylinker primers SK and T7, or synthetic oligo-
nucleotides. Alignment of nucleotide sequences and comparisons were
initially analyzed using DNAstar (DNASTAR, Inc., Madison, WI). Data-
bank searching was carried out using the FASTA program in the GCG pack-
age (Genetics Computer Group, Madison, WI). Predictions for coiled-coil
structure were generated by STRIPE for Macintosh version 1.2 (29).
 
mRNA Isolation and Northern Analysis
 
Total RNA was prepared from confluent cultures of L2 cells and rat tis-
sues by the Ultraspec II total RNA isolation kit (BIOTEX, Houston, TX)
according to manufacturer’s methods. For Northern analysis, 30 
 
m
 
g of to-
tal RNA was electrophoresed on a 0.7% agarose formaldehyde gel, trans-
ferred to nitrocellulose filters, and probed with random primed cDNA
probe F15a, followed by autoradiography. In rat tissue blots, the same fil-
ters were hybridized with a cyclophilin cDNA probe for control purposes.
 
Genomic Southern Blot Analysis
 
Rat genomic DNA was obtained from Clontech (Palo Alto, CA). 1 
 
m
 
g of
DNA was digested with either EcoRI, BamHI, BglI, BglII, PstI, or
EcoRV, electrophoresed in a 0.7% agarose gel, and transferred to a Hy-
bond N
 
1
 
 membrane. The membranes were hybridized with a 
 
32
 
P-labeled
probe that contained the full-length cDNA sequence of bamacan, a 584-bp
segment of the 5
 
9
 
 end of the T2 clone or a 1.4-kb 3
 
9
 
 fragment of clone 12b.
Prehybridization and hybridization were done at 42
 
8
 
C in the presence of
50% formamide, 5
 
3
 
 SSC, 5
 
3
 
 Denhardt’s solution, 1% SDS, and 100 
 
m
 
g/
ml salmon sperm DNA, followed by washes and autoradiography as de-
scribed above.
 
Fusion Proteins, Antisera, and In Vitro
Transcription/Translation
 
The cDNA fragments F4a or F15a (see Fig. 1) were excised from clone 4a
or 15a by digestion with EcoRI and XhoI, and then cloned directly into
pGEX 5X1 or 5X2, respectively (Pharmacia Biotech). The resulting con-
structs encoded fusion proteins of 
 
M
 
r
 
 60K (FP4a) and 55K (FP15a). These
constructs were transformed into 
 
E. coli
 
 XL1-Blue and fusion proteins in-
duced by growth in the presence of isopropylthio-
 
b
 
-
 
d
 
-galactoside. FP4a
was insoluble and purified by sonication in PBS, centrifugation to remove
soluble bacterial elements, resuspension of the pellet with 8 M urea, and
dialysis to 10 mM Tris-HCl, pH 7.4. This resulted in a partially soluble fu-
sion protein, which was affinity purified on glutathione-agarose beads.
FP15a was soluble, directly affinity purified after bacterial lysis by sonica-
tion, eluted with 10 mM glutathione, and dialyzed to PBS. Rabbits were
immunized with FP4a or FP15a to produce R665 and R664, respectively.
R664 antibodies were affinity purified on FP15a coupled to CNBr-acti-
vated Sepharose 4B (Pharmacia Fine Chemicals), eluted with 3.4 M
MgCl
 
2
 
, and dialyzed against PBS. In some cases the antiserum was pread-
sorbed with glutathione-
 
S
 
-transferase.
The overlapping clones T2 and 15a (see Fig. 1) were used to construct
full-length bamacan cDNA. The 5
 
9
 
 portion of T2 was excised by EcoRI
and BsmI and inserted into clone 15a plasmids treated with the same en-
zymes. The full-length construct was then excised from pBluescript SK
 
2
 
plasmid and cloned into pcDNA3 vector (Invitrogen, San Diego, CA) us-
ing EcoRI and ApaI restriction sites.
In vitro transcription and translation were performed with a plasmid
containing full-length cDNA of bamacan, using the TNT-coupled reticulo-
cyte lysate system (Promega) according to the manufacturer’s instruc-
tions. Briefly, 2 
 
m
 
g purified plasmid was transcribed and translated in the
presence of [
 
35
 
S]methionine (translation grade, 110 mCi/ml; DuPont-New
England Nuclear, Wilmington, DE). Products, including negative and pos-
itive (luciferase) controls, were resolved on 3–15% SDS-PAGE and fluo-
rography. Some samples were immunoprecipitated with R664 polyclonal
antibody, using the appropriate preimmune serum as a control (R664/1).
Antibody–antigen complexes were precipitated with protein A–Sepharose 
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4B (Pharmacia Fine Chemicals), washed with PBS, and resolved on SDS-
PAGE followed by fluorography.
A further fusion protein was expressed, encompassing the NH
 
2
 
-termi-
nal portion of bamacan domain V, to ascertain whether one or both serine
residues 1074 and 1081 could be glycanated. The forward primer 5
 
9
 
-AT-
GAGAATTCCCAGTTAACCTTCAAACA-3
 
9
 
 and reverse primer
5
 
9
 
-CTGAGTCGACTAAATGAGAGCAAGGGCT ACCA-3
 
9
 
 were syn-
thesized. The former included a 5
 
9
 
 EcoRI site, the latter a stop codon and
an SalI cleavage site. In a PCR with the full-length bamacan cDNA as a
template, a 320-bp product corresponding to amino acids 1,029–1,128 was
synthesized. It was purified and reconstructed into the eukaryotic expres-
sion vector pRK5F10–protein A (54) at an EcoRI restriction site. Tran-
sient transfection of COS-7 cells (2 
 
3
 
 10
 
5
 
 cells/well in 12-well plates) in
DME with 2 
 
m
 
g/well plasmid were carried out by the DEAE-dextran
method. Control plasmids included empty pRK5F10–protein A vector
and pcDNA3 (Invitrogen). Cells were then labeled with 50 
 
m
 
Ci/ml Trans
 
35
 
S-label, a mixture of [
 
35
 
S]methionine and [
 
35
 
S]cysteine (
 
.
 
1,000 Ci/mmol,
51006; ICN Biomedicals, Inc., Irvine, CA) in DME containing 10% FBS. 1 ml
of conditioned medium was mixed with 10 
 
m
 
l of 1 M Tris-HCl, pH 7.5,
containing 5% Triton X-100 and 2% sodium azide, and clarified by cen-
trifugation at 10,000 
 
g
 
 for 5 min. 20 
 
m
 
l IgG-agarose beads (Sigma Chemi-
cal Co.) were added to the supernatant and mixed overnight at 4
 
8
 
C. The
beads were extensively washed with 50 mM Tris-HCl, pH 8.0, 0.15 M
NaCl, and 0.02% sodium azide, and some samples were further washed in
chondroitinase or heparitinase buffers (11) containing 1 
 
m
 
g/ml pepstatin
A, 1 
 
m
 
g/ml leupeptin, and 1 mM PMSF. These were digested with 10 mU
chondroitinase ABC (EC 4.2.2.4) or 20 mU heparinase III (EC 4.2.2.8;
Seikagaku America, Ijamsville, MD) for 3 h or overnight at 37
 
8
 
C, respec-
tively. Controls were incubated without enzyme under identical condi-
tions. Samples were treated with 2% SDS sample buffer for 5–15% gradi-
ent SDS-PAGE and autoradiography as described previously (11).
Other transiently transfected cultures were labeled with 50 
 
m
 
Ci/ml
 
d
 
-[6-
 
3
 
H]glucosamine HCl (40 Ci/nmol; DuPont-New England Nuclear) in
low glucose medium for 48 h, and the medium and cell layer were har-
vested separately for fusion protein purification as described above and
previously (3). The beads were then subjected to 
 
b
 
-elimination, followed
by glycosaminoglycan purification on DEAE-Sephacel beads (Pharmacia
Biotech). The radiolabeled glycosaminoglycans were then subjected to
chondroitinase ABC or heparinase III digestions as before (3). Empty
vector controls, as above, were also used.
 
Immunofluorescence Microscopy
 
Indirect immunofluorescence microscopy was performed as described
previously (31). Sections of frozen rat kidney or paraffin-embedded hu-
man skin were incubated with affinity-purified R664 serum at 50 
 
m
 
g/ml,
followed by affinity-purified FITC-conjugated goat anti–rabbit IgG F(ab
 
9
 
)
 
2
 
fragments (Organon Teknika-Cappel, Malvern, PA). Sections were exam-
ined and photographed on an Optiphot epifluorescence microscope (Ni-
kon Inc., Garden City, NY).
 
Proteoglycan Preparation, Electrophoresis,
and Immunoblotting
 
Total proteoglycans from L2 yolk sac cell conditioned medium were pre-
pared as described previously (11), eluted from DEAE-Sephacel with 4 M
guanidine-HCl, precipitated in 70% ethanol at 
 
2
 
70
 
8
 
C overnight, and re-
solved by 3–15% SDS-PAGE with or without enzyme treatment. Samples
were digested overnight at 37
 
8
 
C in 15 
 
m
 
l heparinase buffer (0.1 M sodium
acetate, 0.1 mM calcium acetate, 0.1% Tween 20, pH 7.0), containing 0.5–1
mU heparinase III and/or 1–2 mU chondroitinase ABC. 12 
 
m
 
l SDS-
PAGE sample buffer containing 20 mM dithioerythreitol was added be-
fore heating at 100
 
8
 
C for 3 min and electrophoresis. Resolved proteins
were transferred to nitrocellulose membranes and incubated with primary
antibodies, followed by goat anti–rabbit IgG conjugated to alkaline phos-
phatase as before (10, 11).
 
Results
 
Isolation of cDNA Clones
 
The L2 rat yolk sac carcinoma cDNA library was screened
with antiserum R63, raised against murine basement mem-
brane chondroitin/dermatan sulfate proteoglycans, which
has activity against the core proteins of both BM-CSPG
and perlecan (11). 12 positive clones were isolated, puri-
fied by rescreening, and sequenced. Three cDNA clones
showed high homology (
 
.
 
90%) to mouse perlecan cDNA
(36, 38). The remaining nine clones had overlapping se-
quences, which encoded a novel protein sequence and
contained a long open reading frame and a stop codon fol-
lowed by a 480-bp 3
 
9
 
 untranslated region terminating with
a poly (A) tail. A 5
 
9
 
 fragment (F15a) from the cDNA
clone 15a generated two additional positive clones when
used to rescreen the same cDNA library. One, clone T2,
contained both the 5
 
9
 
 untranslated region and 3
 
9
 
 regions
that overlapped with all of the original clones (Fig. 1).
Thus, 11 overlapping cDNA clones yielded a continuous
complete cDNA sequence of this protein (Fig. 2). Bam-
acan cDNA sequence contains 4143 bases, with a single
long open reading frame of 1,191 amino acids, predicting a
molecular mass of 138 kD (Fig. 2). The 3
 
9
 
 untranslated re-
gion of 480 bases extended to a poly (A) tail, preceded by
a polyadenylation signal. Some clones, such as 12a, 13b,
and 15b, had a shorter (375 bp) 3
 
9
 
 untranslated region, linked
to a poly (A) tail. The initiator methionine lies in a nucleotide
sequence homologous to Kozak consensus sequences (27)
and could initiate translation when a complete cDNA was
subjected to in vitro transcription/translation (see below).
 
Domain Structure of the Proteoglycan Core Protein
 
The predicted core protein sequence can be divided into
five domains (I–V; NH
 
2
 
 to COOH terminus). The first 165
amino acids comprise domain I, lacking cysteine and being
largely hydrophilic, with many 
 
b
 
 turns predicted by Chou-
Fasman rules (4), perhaps indicative of globular structure.
One sequence NGSG at the NH
 
2
 
 terminus is potentially
glycosylated but does not lie in an acidic context shown to be
optimal for glycanation (54). Domain II, comprising 335
amino acids, has a very high potential for coiled-coil struc-
ture (Fig. 3) with one small interruption between amino
acids 216 and 223, and a larger one between amino acids 349
and 394. Consistent with a coiled-coil structure, proline
residues are absent, except at residue 349 marking the ini-
Figure 1. Schematic diagram of cDNA clones isolated from a rat
L2 cell Uni-ZAP library. T1 and T2 clones were isolated by
screening with the 59 end of clone 15a (F15a). All other clones
were identified by R63 antibody screening. The 59 ends of clones
15a and 4a (F15a and F4a) were used to subclone into pGEX vec-
tors for fusion protein production. 
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tiation of an interruption. Each break also contains a sin-
gle tryptophan residue, which is otherwise absent from do-
main II. Adjacent to the first predicted interruption is one
potential N-glycosylation site, followed 14 residues down-
stream by a Ser-Gly dipeptide, which is a possible glycana-
tion site since it is surrounded by acidic residues (54).
Domain III lies between two coiled-coil regions and
comprises 165 amino acids with no apparent glycosylation
Figure 2. Nucleotide and deduced amino acid sequence of bamacan
core protein. Aligned sequence from all of the clones shown in Fig. 1 is
shown, together with the translation of 3,573 bp of open reading frame.
Six Ser-Gly dipeptides are boxed, and the three most likely to be substi-
tuted with chondroitin sulfate chains are additionally underlined. Three
potential N-glycosylation sites are double underlined. The putative
boundaries between each of the five domains are marked by arrows.
These sequence data are available from the GenBank/EMBL/DDBJ
under accession number U82626. 
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sites. Four cysteine residues are present in this domain:
one pair approximately one third from the NH
 
2
 
 terminus
of this domain, and the other pair close to its COOH ter-
minus. Between the first and third cysteine residues are six
proline residues, consistent with some flexibility in this re-
gion. There is a VTXG sequence at residues 552–555,
which may be a cell adhesion site homologous to that of
thrombospondin 1 (50).
Domain IV consists of a second predicted coiled-coil re-
gion (Fig. 3) of very similar size to domain II (364 amino
acids), starting at residue 665 and terminating at residue
1,029. There are again two internal interruptions in the
putative coiled-coil structure (residues 737–756 and 947–
961), which are both small and contain a single proline res-
idue in an otherwise proline-depleted sequence. The sec-
ond break in the coiled-coil structure is also bounded on
each side by a single cysteine residue. Two potential N-gly-
cosylation sites are present close to the junction of do-
mains IV and V. An LRE sequence is also present (at resi-
dues 850–852), and this has previously been shown to be a
cell adhesion site in the laminin 
 
b
 
2 chain (S-laminin; 20).
The COOH-terminal domain V contains 162 amino acids
and four Ser-Gly dipeptides that are possible sites of gly-
cosaminoglycan substitution. The most NH
 
2
 
-terminal two
Ser-Gly dipeptides, in particular, have associated acidic
residues and are proximal to each other. The fourth is very
close to the COOH terminus, while the third lies at the be-
ginning of a putative helix-loop-helix structure.
 
Proteins with Homology to the Bamacan Core Protein
 
A GenBank database search revealed no other proteogly-
can core proteins with this structure. However, several
other proteins, from yeast (40, 44, 47), 
 
Caenorhabditis ele-
gans
 
 (5), and vertebrates (
 
Xenopus
 
, chick, and human; 17,
42, 43), have overall homology (Fig. 4). Each is predicted
to have a similar five domain structure, with two internal
coiled-coil domains, as described above (for review see
18). However, the overall sequence homology of bamacan
with these other proteins, even of vertebrate origin, is low
(Fig. 4). Some of these proteins have been proposed to be
involved in stabilization of mitotic chromosomes (SMC)
and are therefore intracellular. Bamacan, however, is an
extracellular, secreted proteoglycan (see below). Despite
high homology between chick and amphibian proteins ScII
and XCAP-E (67% amino acid identity), that between the
chick and the bamacan sequence shown here is very low
(
 
,
 
20%). The human SB1.8 gene (42) is homologous with
yeast Smc1 protein since there is 30% amino acid identity
throughout the five domains, with up to 50% identity in
regions of domains I and V. However, the SB1.8 gene, de-
spite being mammalian, has only a 17% identity to bam-
acan. This is indicative of different functional attributes
and is underscored by dendrogram analysis, showing the
distant relationship between bamacan and the SMC pro-
teins including the SB1.8 gene product (Fig. 4).
Two small regions of all these proteins (one each in do-
mains I and V) have a conserved region with higher se-
quence homology to bamacan (Fig. 5). At the NH
 
2
 
 termi-
nus in domain I, a sequence NGSGKSN is completely
conserved, together with some additional flanking se-
quence. This structure is homologous to a P-loop and, per-
haps, part of an NTP-binding site (GXXXXGKS), but
other requirements are not met in this or some of the
other related proteins (5, 18, 43).
Domain V contains a 35–amino acid region that, in yeast
Smc1 protein and possibly the other proteins, apparently
contributes to a helix-loop-helix domain. However, none
of these proteins has a preceding basic region, common in
DNA-binding helix-loop-helix motifs (18). In bamacan, an
acidic region containing potential glycosaminoglycan sub-
stitution sites lies upstream. Most striking among all these
Figure 3. Domains II and IV have a high probability of forming
coiled-coil structures. Analysis of the predicted amino acid se-
quence was generated by STRIPE for Macintosh version 1.2 (19).
Figure 4. Dendrogram analysis showing the relationship between
bamacan core protein and other members of the SMC family of
proteins. While the chicken ScII and Xenopus XCAP-E are
closely related, for example, bamacan is only distantly related to
all other members.
Figure 5. Conserved sequences in bamacan core protein and re-
lated proteins. One small region in each of domains I and V
shows high sequence homology, shown within boxed areas. The
sequences shown represent amino acid residues 25–65 and 1,107–
1,158 of bamacan core protein. 
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proteins is the conservation of the initial SGG, as well as
the subsequent acidic, some hydrophobic, and two proline
residues. Alone among the vertebrate sequences, bamacan
possesses a single cysteine residue in the center of this mo-
tif, in place of tyrosine or phenylalanine. Also of note, the
yeast Smc1 protein has a nuclear localization sequence
within domain V that is not shared by the bamacan or
other sequences.
 
Northern and Genomic DNA Analyses
When total RNA isolated from L2 cells was subjected to
Northern analysis, one band, migrating faster than the ri-
bosomal 28S, was detected when probed with a full-length,
random-primed bamacan construct. The estimated size
was 4.2 kb (Fig. 6 A), which corresponded to the size of the
cDNA sequenced from the L2 cell library. mRNA of a
very similar size was detected in Northern blots of numer-
ous rat tissues (Fig. 6 B). All these tissues contain base-
ment membranes and expressed bamacan mRNA in vary-
ing amounts. A Southern blot of rat genomic DNA cut
with restriction enzymes for which no internal sites in the
cDNA were present and probed with a 1.4-kb probe from
the 39 end of the cDNA revealed in each case two major
bands (Fig. 7). A similar result was obtained in Southern
blots probed with either full-length cDNA or the most 59
region (584 bp). The results indicate that in all probability
there is a single gene for bamacan.
Reactivity of Fusion Protein Antibodies
Two antisera were prepared. Antiserum R665 generated
from FP4a fusion protein could detect the bamacan core
protein in immunoblots but did not recognize the native
protein in immunofluorescence microscopy of rat tissue sec-
tions. In contrast, affinity-purified R664 antiserum against
FP15a fusion protein recognized both native and dena-
tured protein. Both R665 and R664 antisera recognized
one major band, representing the core protein of a CSPG
in Western blots of L2 proteoglycan preparations (Fig. 8).
This core protein had Mr of z190K and was seen only af-
ter chondroitinase ABC treatment, not after heparinase
III treatment. Intact proteoglycans with chondroitin chains
attached did not enter the resolving gel. These antisera also
Figure 6. Northern blots of mRNA prepared from rat L2 cells
(A) and various rat tissues (B). In each case, the blots were
probed with a radiolabeled region corresponding to clone F15a
(see Fig. 1). 28S and 18S standards are shown. In A, two duplicate
lanes are shown, and, in B, the blot was reprobed with cyclophilin
cDNA for loading comparison.
Figure 7. Southern blot of genomic rat DNA cleaved with the re-
striction enzymes shown and probed with a 1.4-kb fragment of
bamacan cDNA from clone 12b. In each case, two major bands
are visible, consistent with a single gene for bamacan. The migra-
tion of standards is shown.
Figure 8. Western blot of total L2 proteoglycans probed with af-
finity-purified R664 polyclonal antibodies against a fusion pro-
tein prepared using clone F15a (see Fig. 1). The proteoglycans
were untreated (lane 1) or pretreated with heparinase III (lanes 2
and 3) and/or chondroitinase ABC (lanes 3 and 4). A core pro-
tein is only clearly resolved after removal of chondroitin sulfate
chains. The migration of molecular mass markers in kD is shown.Wu and Couchman Basement Membrane Proteoglycan Core Protein 439
detected a smaller CSPG core protein of Mr z130K after
chondroitinase ABC treatment, possibly resulting from
degradation of the 190-kD protein (11). When the antise-
rum R63, which was used to perform primary screening of
the cDNA expression library, was used as a positive control
in immunoblotting, the same sizes of CSPG core protein
were detected (11) in addition to perlecan. In contrast, the
fusion protein antisera did not react with rat perlecan.
When sections of adult rat kidney and human skin were
stained with affinity-purified R664, only basement mem-
branes were labeled (Figs. 9 and 10). R664 specifically la-
beled the dermo-epidermal junction and the basement
membranes of blood vessels and nerves. In kidney, tubular
basement membranes were labeled, together with the me-
sangium and Bowman’s capsule basement membranes of
glomeruli, while the glomerular basement membrane was
negative for this antigen (Fig. 10 B). The specific distribu-
tions were closely similar to those seen with the initial
screening antibody R63 and identical to that of BM-CSPG
(now termed bamacan), described earlier with monoclonal
core protein-specific antibodies (31, 33).
In Vitro Transcription/Translation of Bamacan cDNA
A full-length construct, prepared from two overlapping
clones, was subjected to in vitro transcription and transla-
tion in a TNT-coupled reticulocyte lysate system. The cDNA
was efficiently transcribed and translated to reveal a single
140-kD polypeptide as anticipated from the predicted se-
quence (Fig. 11). The polypeptide was immunoprecipi-
tated by antiserum R664 raised against domain II fusion
protein, but not by the corresponding preimmune serum.
Chondroitin Sulfate Substitution of Bamacan
Domain V
At residues 1074/5 and 1081/2 are Ser-Gly dipeptides po-
tentially suitable for glycanation. A PCR product was gen-
erated, corresponding to the first 99 amino acids of do-
main V (residues 1,029–1,128), and ligated in-frame with
DNA encoding the IgG-binding portion of protein A in
the pRK 5F10 vector. Transfection into COS-7 cells fol-
lowed by metabolic labeling with 35S–amino acids gave rise
to a product that was resolved as a broad smear on SDS-
PAGE in untreated or heparinase III–treated samples, but
as a discrete product after chondroitinase ABC (Fig. 12).
This is consistent with galactosaminoglycan substitution
of the fusion protein. Negative controls of pRK5F10 or
pcDNA3 vector did not yield patterns consistent with pro-
teoglycan synthesis.
In further experiments (not shown), the same trans-
fected cells were grown in the presence of [3H]glu-
Figure 9. Indirect immunofluorescence microscopy of human skin sections stained with R63 polyclonal antibody recognizing basement
membrane CSPGs (A and C), and affinity-purified R664 polyclonal antibody against a bamacan fusion protein (B and D). The dermal-
epidermal junction and subjacent capillaries are stained in A and B, while the basement membranes of eccrine sweat glands and their as-
sociated vasculature are stained in C and D. Bars, 50 mm.The Journal of Cell Biology, Volume 136, 1997 440
cosamine. Only the vector containing the NH2-terminal re-
gion of domain V yielded a labeled product binding to
IgG-agarose and sensitive to b-elimination and chon-
droitinase ABC. Heparinase III failed to degrade this met-
abolically labeled product. Overall, the results show that
the Ser-Gly dipeptides at the NH2-terminal region of bam-
acan domain V are favorable for chondroitin/dermatan
sulfate substitution.
Discussion
This report describes the cDNA cloning of a novel base-
ment membrane proteoglycan core protein. While this
Figure 10. Frozen sections of rat kidney stained with R63 (A), affinity-purified R664 (B), or 2D6 mAb against bamacan core protein. In
each case, all tubular, blood vessel, and Bowman’s capsule basement membranes are stained, as are mesangia, but the glomerular base-
ment membranes are weak or unstained. Bars, 100 mm.
Figure 12. Glycanation of the NH2-terminal region of bamacan
domain V. Autoradiogram of 5–15% gradient SDS-PAGE of pro-
tein A–bamacan fusion protein, heparinase III treated (lane 1),
chondroitinase ABC treated (lane 2), or untreated (lane 5). Only
after chondroitinase ABC treatment is a discrete protein resolved
(arrows denote fusion protein of Mr z 50K). (Lane 3) Result
from transfection of empty pRK5F10 vector; (lane 4) equivalent
from empty pcDNA 3 vector (which fails to bind Ig-agarose).
Figure 11. (A) In vitro transcription/translation of full-length
bamacan cDNA (lane 1), luciferase cDNA (lane 2, positive con-
trol), or vector only (lane 3, negative control). Appropriately
sized proteins were transcribed and translated. (B) Immune
R664/4, but not preimmune antibodies from the same rabbit
(R664/1), immunoprecipitated the protein transcribed and trans-
lated from full-length bamacan cDNA. The migration of molecu-
lar mass markers in kD is shown in A and B.Wu and Couchman Basement Membrane Proteoglycan Core Protein 441
CSPG was described some years ago (21, 31, 32), its rela-
tionship to other basement membrane components and
proteoglycans was unclear. With this description of its
cDNA sequence, we can now determine that it is both to-
tally distinct from other known basement membrane com-
ponents, including the large HSPGs perlecan and agrin,
and from any other previously cloned proteoglycan core
protein. It does not appear to be a member of any of the
currently known extracellular matrix proteoglycan families,
such as the aggregating proteoglycans containing aggre-
can, versican, neurocan, and brevican (52), or the leucine-
rich interstitial proteoglycans such as decorin, lumican,
and biglycan (28). Whether this CSPG (bamacan) repre-
sents the prototypical form of a novel proteoglycan family
remains to be seen, and it is still not clear whether this core
protein represents the only basement membrane CSPG.
One aspect of similarity of bamacan with neurocan in
terms of glycosylation may be functionally relevant. In
both cases, chondroitin chains are present near the junc-
tions between both of the NH2- and COOH-terminal glob-
ular domains and the central, internal rod segment. In
addition, the three potential N-glycosylation sites in bam-
acan are also in these regions (Fig. 13; reference 41).
The predicted mass of the core protein is z138 kD, close
to previous estimates of 150–160 kD obtained from chon-
droitinase ABC–digested Reichert’s membrane proteogly-
cans (21, 32), which would still bear any N- or O-linked
oligosaccharides and glycosaminoglycan stem structures.
Western blots of L2 and EHS tumor CSPGs revealed a
core protein of zMr 5 190K after chondroitinase ABC
treatment (11), perhaps indicative of more extensive N- or
O-linked glycosylation. The potential for three N-linked
oligosaccharides is predicted from the putative sequence.
The most striking feature of the core protein is that it
contains two long regions (domains II and IV) predicted
to form coiled-coil structures that comprise .50% of the
protein sequence. These are flanked by NH2- and COOH-
terminal noncoiled regions and interrupted by a central
cysteine and proline-containing domain III (Fig. 13). This
structure has not been seen in any proteoglycan core pro-
tein previously documented and is unlike any other base-
ment membrane component. However, it has been dem-
onstrated that laminin isoforms participate in extensive
coiled-coil structures, forming heterotrimeric complexes
stabilized by disulfide bonds (14). Currently, we do not
have information regarding the nature of the coiled-coil
interactions undertaken by bamacan core protein, but pre-
sumably it may form homo- or heteropolymeric com-
plexes. One feature shared with laminin b2 chain is the
presence of an LRE sequence in domain IV. This has been
shown to be a cell attachment site unique to this laminin
chain, but whether the site in bamacan can fulfill the same
function is unknown. Certainly the structural context is
distinct, and the surrounding sequences are dissimilar (20).
The only other recognizable potential cell attachment site
is a VTXG motif in domain III, shown previously to be ac-
tive in thrombospondin 1 (50). There are no RGD-con-
taining sequences in this core protein.
Database searching reveals that, while there are no ex-
tracellular proteins with very high homology to bamacan,
related molecules have been identified in diverse organ-
isms from yeast to vertebrates. Some are nuclear proteins
proposed to take part in stabilizing chromosome scaffolds
at mitosis (SMC proteins; 18). Neither fusion protein anti-
bodies nor the original R63 antibody used in library
screening had the capacity to stain mitotic figures in colce-
mid-treated fibroblasts, where some SMC proteins such as
avian ScII become localized (17, 40, 43, 44, 47). Antibodies
against the chick ScII protein did stain these structures
(Woods, A., R.R. Wu, and J.R. Couchman, unpublished
observations). In overall terms, the sequence homology
between bamacan core protein and the SMC proteins is
low (Figs. 4 and 5). However, a striking similarity in pre-
dicted protein structure is apparent, each having the same
five domain (head-rod-tail) pattern, with each domain com-
parable with its homologues in terms of size and predicted
secondary structure. Each protein, therefore, like bam-
acan, has two similarly sized domains (II and IV) pre-
dicted to form coiled-coil structures. However, while the
homology between the other proteins from distant species
can be high (Fig. 4), that with bamacan is low, even with
the human SB1.8 protein. This is indicative of distinct
function and supported by the dendrogram showing a
wide separation between bamacan and vertebrate SMC
proteins (Fig. 4). In contrast, our preliminary sequence
data for human bamacan cDNA indicates .95% identity
with the rat core protein, further suggesting wide func-
tional and evolutionary separation of SMC proteins and
the proteoglycan, yet highly conserved bamacan domains,
including the coiled-coil regions. A recent review of SMC
proteins suggested three separate subfamilies, based on se-
quence and structural data (18). We propose bamacan be-
longs to a fourth distantly related but structurally homolo-
gous subfamily, having distinct roles and interactions.
Bamacan has many distinct features not shared with the
other homologous proteins. Its core protein has three po-
tential N-glycosylation sites and six Ser-Gly peptides. How-
ever, not all of these Ser-Gly motifs are in an acidic envi-
ronment (54), which indicates that not all of them may
be substituted with chondroitin sulfate chains. Two are
within motifs shared by all members of this group, but the
three most favorable for substitution (in domains II and
V; Fig. 13) are not shared with the other proteins. Indeed,
two closely spaced SG dipeptides in domain V within the
sequence VEGSQSQDEGEGSGESERGSGSQSSVP lie
in a region totally lacking homology with all other related
proteins, and it is perhaps an inserted region substituted
with chondroitin sulfate chains. This region was expressed
in COS-7 cells as a fusion protein with the Ig-binding do-
Figure 13. Schematic representation of bamacan, showing the
five domain structure and three potential N-linked oligosaccha-
rides (short lines), as well as the three chondroitin sulfate chains
with the highest probability for substitution.The Journal of Cell Biology, Volume 136, 1997 442
main of protein A. It was recovered from supernatants in a
glycanated form, sensitive to chondroitinase ABC but not
heparinase III (Fig. 12). This further confirms the pro-
teoglycan nature of bamacan. Perlecan has three closely
spaced SG dipeptides at its NH2 terminus, again lacking in
homology with other molecules, seemingly indicative of
a requirement for unique protein sequences that bear
glycosaminoglycans (6, 22, 37). The sequence GEGSGE
found within this unique region of bamacan domain V is
also present in the glycosaminoglycan attachment (V1) re-
gion of the aggregating CSPG PG-M (24). It is also present
in the hybrid transmembrane proteoglycan, syndecan 1
(30,46), where again it is believed to be substituted with
chondroitin sulfate (26). The other potential chondroitin
sulfate substitution site in syndecan 1 with the sequence
ETSGE is, remarkably, also present in the bamacan core
protein, at residues 247–251 at the NH2-terminal region of
domain II, and is favorable for glycosaminoglycan substi-
tution. However, despite these very small sequence identi-
ties, bamacan is not at all similar to syndecan 1 in any
other respect.
The yeast Smc1 protein and others contain an incom-
plete dNTP-binding site, some elements of which were
conserved in the proteoglycan core. One other site was
similarly conserved, where part of domain V potentially
forms a helix-loop-helix structure. This motif is commonly
associated with DNA binding, unlikely in the case of the
basement membrane proteoglycan. An upstream cationic
region found in DNA-binding structures is absent in bam-
acan. Helix-loop-helix structures are also found in the ma-
trix glycoprotein SPARC and proteoglycan testican (1, 19),
where they form Ca11-binding EF-hand motifs also com-
mon to many intracellular proteins. The bamacan se-
quence, as those of the SMC proteins, does not appear to
form EF-hand structures.
That this is, indeed, a basement membrane core protein
was verified in several ways, in addition to verification of
the suitability of domain V to be chondroitin sulfate sub-
stituted. Affinity-purified fusion protein antibodies recog-
nized the appropriate CSPG core protein prepared from
cultures of rat L2 yolk sac carcinoma cells, and stained rat
and human tissue sections in a basement membrane–spe-
cific manner. Especially noteworthy was the absence of
staining in rat glomerular capillary basement membranes,
a hallmark of BM-CSPG distribution (31, 33). In all re-
spects, the staining obtained with the fusion protein anti-
bodies matched that described before with core protein–
specific mAbs. This pattern is therefore distinct from the
structurally related SMC proteins, which have an intracel-
lular localization (18, 40). When a full-length bamacan
core protein cDNA construct was subjected to in vitro
transcription/translation, it yielded a product of Mr
z140K, which could be immunoprecipitated by fusion
protein antibodies.
Many proteins, in the course of evolution, have acquired
novel functions associated with new locations. The leucine-
rich repeat family of proteins, for example, includes inter-
stitial matrix proteoglycans, as well as cytoplasmic, cell
surface, or nuclear proteins (for review see 25). In each of
these examples, the leucine-rich repeat structure is inte-
gral to the protein function, and all take part in protein–
protein interactions. More than one structural motif is
conserved between the SMC proteins and bamacan core
protein, indicating that the entire molecule is required for
structural and/or functional activity, possibly determining
homo-or heteropolymerization (18). It has been proposed
that, in Xenopus, head-to-tail heterodimers of XCAP-C
and XCAP-E assemble, in which case the overall structure
of the five domains may be required (17). This would also
be consistent with the overall symmetry of the molecule,
the two coiled-coil domains being of approximately equal
size. However, as was recently pointed out, antiparallel as-
sociation has not been described in proteins with long
coiled-coil domains (18). In the case of yeast Smc2 protein,
it has been shown that homotypic and heterotypic associa-
tion with other SMC proteins may form (48). It will be in-
teresting to determine the structural relationships of the
bamacan core protein.
We have hypothesized previously that bamacan may act
as a stabilizing factor for the basement membrane matrix
(7). This was based on indirect evidence arising from its lo-
calization through development of such organs as skin and
kidney (9, 33), and from the fact that, in rat models of
polycystic kidney disease and streptozotocin-induced dia-
betes, the distribution of this basement membrane compo-
nent undergoes marked changes (13, 34). In addition, we
and others have previously shown that chondroitin sulfate
is abnormally diminished or absent in basement mem-
branes of the dermal-epidermal junction in patients with
dystrophic forms of epidermolysis bullosa, as well as in
some epidermal tumors (15, 39). Such conditions are
known to be associated with basement membrane fragility.
Analogous to the structural role proposed for the SMC
proteins, the overall structure of this core protein, with its
potentially rigid coiled-coil domains, is consistent with a
role in basement membrane integrity. Domains I and V, in
addition to potentially interacting with each other, may
undergo heterotypic interactions to incorporate the pro-
teoglycan in the matrix, while other interactions may in-
volve the glycosaminoglycan chains. This proteoglycan
core protein is quite distinct from perlecan, but it is never-
theless not the only basement membrane proteoglycan
core protein that may bear galactosaminoglycan chains.
Perlecan itself is usually an HSPG, but it can bear addi-
tional or alternate dermatan sulfate chains (11, 12, 16, 23).
The significance of this variable glycanation is not under-
stood but presumably impacts its interactions and func-
tional attributes. Bearing in mind the quite distinctive
structural features of bamacan core protein, it is likely that
it has a quite distinct and separable function, which will be
the subject of future research now that the core protein
structure has been more fully elucidated.
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